2D-QSAR of purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells

被引:0
|
作者
Supriya Singh
Anil K. Saxena
机构
[1] Research Institute,Medicinal and Process Chemistry Division Central Drug
来源
Medicinal Chemistry Research | 2008年 / 17卷
关键词
Hsp90 Inhibitor; Purine Derivative; Molar Refractivity; Physiochemical Parameter; Trimethoxyphenyl;
D O I
暂无
中图分类号
学科分类号
摘要
The chaperone heat shock protein 90 (Hsp90) is an emerging target for designing anticancer agent due to its important roles in maintaining transformation and modulating the survival and growth potential of cancer cells. Quantitative structure–activity relationship (QSAR) studies have been carried out in a series of purine derivatives with Hsp90 inhibitory activities. The two-diemensional (2D) QSAR studies revealed that the activity is positively influenced by the presence of a halo substituent in the trimethoxyphenyl moiety and by electronic parameter (field effect) of the 9-N substituent where the contribution of the steric parameter (MR) is negative. The best QSAR model with good correlation coefficient (r2 = 0.738), of high statistical significance (>99.9%) well explained the variance in activity.
引用
收藏
页码:290 / 296
页数:6
相关论文
共 50 条
  • [21] Inhibition of thyroid cancer proliferation in vitro by a novel small molecule HSP90 inhibitor
    Cohen, Mark S.
    Patton, Brianne
    Hirsch, Brian
    Rohr, Melanie
    Herre, William
    Blagg, Brian
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3604S - 3604S
  • [22] The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
    Saad Z Usmani
    Robert D Bona
    Gabriela Chiosis
    Zihai Li
    Journal of Hematology & Oncology, 3
  • [23] The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
    Usmani, Saad Z.
    Bona, Robert D.
    Chiosis, Gabriela
    Li, Zihai
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3
  • [24] Hydroxamic Acids Analogous Against Breast Cancer Cells: 2D-QSAR and 3D-QSAR Studies
    Rajwade, Ram Prakash
    Pande, Rama
    Mishra, K. P.
    Kumar, Amit
    Pandey, B. N.
    QSAR & COMBINATORIAL SCIENCE, 2009, 28 (11-12): : 1500 - 1508
  • [25] 3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold
    Abbasi, Maryam
    Sadeghi-Aliabadi, Hojjat
    Amanlou, Massoud
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (06): : 1463 - 1478
  • [26] 2D-QSAR Studies on Phenoxybenzoic Acid Derivatives: A Novel Class of 5a-Reductase Inhibitors
    欧敏锐
    李俊篯
    结构化学, 2008, (01) : 105 - 111
  • [27] 2D-QSAR studies on phenoxybenzoic acid derivatives: A novel class of 5a-reductase inhibitors
    Ou Ming-Rui
    Li Jun-Qian
    CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2008, 27 (01) : 105 - 111
  • [28] HSP90 inhibition in HER2-positive breast cancer cells
    Qadir, Z.
    Crown, J.
    Jensen, M. R.
    Clynes, M.
    Slamon, D.
    O'Donovan, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Metformin inhibits proliferation and promotes apoptosis of HER2 positive breast cancer cells by downregulating HSP90
    Chen Tian-wen
    Liang Ya-nan
    Feng Duo
    Tao Lin-yu
    Qi Ke
    Zhang Hao-yun
    Wang Hong-xian
    Lin Qiu-sheng
    Kong Heng
    JOURNAL OF BUON, 2013, 18 (01): : 51 - 56
  • [30] 2D-QSAR Studies on Phenoxybenzoic Acid Derivatives: A Novel Class of 5a-Reductase Inhibitors
    欧敏锐
    李俊篯
    Chinese Journal of Structural Chemistry, 2008, (01) : 105 - 111